Ascletis Pharma Inc announced that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical development candidate. Ascletis ...
How will our healthcare sector be in 2050? Let us imagine. Present trends and happenings forecast what is in store for us in the future. There will be lakhs of doctors, nurses, pharmacists and lab ...
PharmaDrug executes definitive agreement with Canurta Limited Partnership to buy 40% equity interest in Canurta: Toronto, Ontario Saturday, November 1, 2025, 17:00 Hrs [IST] Pharm ...
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the ...
SpectronRx commences mass production of high-purity Actinium-225, to strengthen global supply for cancer therapies: Indiana Saturday, November 1, 2025, 15:00 Hrs [IST] SpectronRx, ...
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
But, the heartless counterfeiters have gone one step further as recent investigations by the drug authorities have exposed a clandestine operation involving the inter-state distribution of counterfeit ...
PREVAIL phase III trial of gefurulimab meets its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement from baseline in MG-ADL ...
Bagsværd, Denmark Saturday, November 1, 2025, 12:00 Hrs [IST] Novo Nordisk, a leading global healthcare company founded in 1923 and ...
Cellectricon broadens discovery capabilities with launch of Neurotoxicity Testing Services: Molndal, Sweden Saturday, November 1, 2025, 11:00 Hrs [IST] Cellectricon, a services pr ...
Codexis & Nitto Denko Avecia ink evaluation agreement to explore Codexis’s ECO Synthesis Manufacturing Platform for therapeutic siRNA manufacturing: Redwood City, California Sat ...
Nandita Vijayasimha, Bengaluru Saturday, November 1, 2025, 08:00 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results